<?xml version="1.0" encoding="UTF-8"?>
<ref id="B333-pharmaceuticals-14-00381">
 <label>333.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Le Douce</surname>
    <given-names>V.</given-names>
   </name>
   <name>
    <surname>Janossy</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Hallay</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Ali</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Riclet</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Rohr</surname>
    <given-names>O.</given-names>
   </name>
   <name>
    <surname>Schwartz</surname>
    <given-names>C.</given-names>
   </name>
  </person-group>
  <article-title>Achieving a cure for HIV infection: Do we have reasons to be optimistic?</article-title>
  <source>J. Antimicrob. Chemother.</source>
  <year>2012</year>
  <volume>67</volume>
  <fpage>1063</fpage>
  <lpage>1074</lpage>
  <pub-id pub-id-type="doi">10.1093/jac/dkr599</pub-id>
  <?supplied-pmid 22294645?>
  <pub-id pub-id-type="pmid">22294645</pub-id>
 </element-citation>
</ref>
